THE PREVALENCE AND ETIOLOGY OF LONG-TERM L-DOPA SIDE-EFFECTS IN ELDERLY PARKINSONIAN-PATIENTS

被引：17

作者：

WILSON, JA

SMITH, RG

机构：

来源：

AGE AND AGEING | 1989年 / 18卷 / 01期

关键词：

D O I：

10.1093/ageing/18.1.11

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：11 / 16

页数：6

共 27 条

[1] RENIN-ALDOSTERONE SYSTEM IN PARKINSONS DISEASE [J].

BARBEAU, A ;

GILLOJOF.L ;

BOUCHER, R ;

NOWACZYNSKI, W ;

GENEST, J .

SCIENCE, 1969, 165 (3890) :291-+

[2]

BARBEAU A, 1981, RES PROGR PARKINSONS, P241

[3]

BROE GA, 1982, NEUROLOGICAL DISORDE, P124

[4]

CALNE DB, 1979, INTERDISCIPLINARY TO, V15, P179

[5]

DENHOLM M, 1982, INT MED PARKINSONISM, P11

[6]

DUVOISIN RC, 1983, PARKINSONS DISEASE G, P81

[7] GASTRIC-EMPTYING RATE AND THE SYSTEMIC AVAILABILITY OF LEVODOPA IN THE ELDERLY PARKINSONIAN PATIENT [J].

EVANS, MA ;

BROE, GA ;

TRIGGS, EJ ;

CHEUNG, M ;

CREASEY, H ;

PAULL, PD .

NEUROLOGY, 1981, 31 (10) :1288-1294

[8] SYSTEMIC AVAILABILITY OF ORALLY-ADMINISTERED L-DOPA IN THE ELDERLY PARKINSONIAN PATIENT [J].

EVANS, MA ;

TRIGGS, EJ ;

BROE, GA ;

SAINES, N .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (03) :215-221

[9]

EXTONSMITH AN, 1978, RECENT ADV GERIATRIC, P85

[10]

GRANERUS AK, 1978, ACTA MED SCAND, V203, P75

← 1 2 3 →